Medical advances improve bile duct cancer outcomes

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/medical-advances-improve-bile/id4318... Patients with cholangiocarcinoma (bile duct cancer), show no signs of the disease early on. Bile duct cancer usually presents at an advanced stage, which carries a poor prognosis. New advances in medical treatment offer hope. Milind Javle, M.D., associate professor in Gastrointestinal Medical Oncology at MD Anderson Cancer Center, discusses new therapies for bile duct cancer, including,...

Neuropathy and other nerve problems during cancer treatment

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/neuropathy-other-nerve-problems/id43... During cancer treatment, adverse nerve and muscular side effects are common. Unfortunately, there is no treatment that will prevent these conditions, but there are therapies to help relieve these side effects. Ivo Tremont, M.D., and Karin Woodman, M.D., both assistant professors in Neuro-Oncology at MD Anderson Cancer Center, discuss some of the common neurologic and muscular disorders that...

Gallbladder cancer: rare and often misdiagnosed

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/gallbladder-cancer-rare-often/id4318... Gallbladder cancer is often misdiagnosed as liver cancer and is difficult to detect early since there are no symptoms at onset. Approximately 5,000 cases are diagnosed in the United States each year, but incidence is increasing with young Latinos in the southern part of the country. Listen to Milind Javle, M.D., associate professor in Gastrointestinal Medical Oncology at MD Anderson Cancer...

Hope for leptomeningeal disease (LMD)

submitted by: mdanderson
Leptomeningeal disease (LMD), which is also referred to as leptomeningeal carcinomatosis (LC), is a rare complication of cancer where the disease spreads to the membranes (meninges) surrounding the brain and spinal cord. Having a diagnosis of LMD may feel grim, but Cynthia Weisinger, a LMD and stage four breast cancer patient at MD Anderson Cancer Center, represents hope. Cynthia was diagnosed with LMD by Ivo Tremont, M.D., assistant professor of Neuro-Oncology, in October 2013 and is now...

United to End Cancer

submitted by: mdanderson

There are those who stand together to make a difference in the fight against cancer — The University of Texas MD Anderson Cancer Center’s community of donors. From across the world and all walks of life, these diverse supporters are united in their generosity toward the Moon Shots Program, the most ambitious assault on cancer ever undertaken by a single institution.

For more information and to make a donation, visit: mdanderson.org/gifts

Personalized treatment for ovarian cancer

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/personalized-treatment-for/id4318482... MD Anderson Cancer Center now has a more strategic approach to treating ovarian cancer which results in a 68% higher rate of removing the whole cancer tumor. Previously, all new ovarian cancer patients would undergo surgery to explore the extent of the disease and remove as much of it as possible. Under this new protocol, all patients undergo this procedure to determine if chemotherapy may...

Lung Cancer Moon Shot update

submitted by: mdanderson
Lung cancer is being fought on three fronts at MD Anderson Cancer Center: prevention, early detection and treatment of advanced disease. John Heymach, M.D., Ph.D., professor in Thoracic/Head and Neck Medical Oncology at MD Anderson, talks about new developments in lung cancer research including advances in genetic mapping, molecular profiling, diagnostic imaging and lung cancer screening. With lung cancer being a part of the MD Anderson’s Moon Shots Program, we have a chance to make lung...

Improved chemotherapy administration reduces chance for medication errors

submitted by: mdanderson

MD Anderson Cancer Center is the first hospital in the United States to implement a new technology that will greatly improve chemotherapy quality control. Our main goal is patient safety. Kelley Reece, assistant manager in Pharmacy, explains how this software helps standardize the delivery of care across technicians and clinics. She also gives a behind the scenes look at how chemotherapy drugs are individually prepared for each unique patient.

Chronic Lymphocytic Leukemia Moon Shot (CLL) update

submitted by: mdanderson

Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses new advances in treating CLL, including alternatives to chemotherapy and using one’s own immune system to fight this disease.

Immunotherapy: unleashing immune system to attack cancer

submitted by: mdanderson
Cancer immunotherapy treats the immune system rather than the tumor. Jim Allison, Ph.D., professor in Immunology at MD Anderson Cancer Center, has developed an innovative approach that will open doors for treating all types of cancer. Padmanee Sharma, M.D., Ph.D., associate professor in Genitourinary Medical Oncology and Immunology, is lead scientist on immunotherapy clinical trials. Listen to Allison and Sharma discuss their collaboration on MD Anderson’s Moon Shots Program to develop...